Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia - Related Studies

Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia

This study is ongoing, but not recruiting participants.

Study NCT00002778. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Leukemia

2	Additional conditions recognized in this trial
		Leukemia, Myelogenous, Chronic, BCR-ABL Positive
		Leukemia, Myeloid

3	More general conditions related to this trial
		Bone Marrow Diseases
		Hematologic Diseases
		Myeloproliferative Disorders
		Neoplasms
		Neoplasms by Histologic Type

4	Interventions listed in this trial
		sargramostim
		therapeutic allogeneic lymphocytes

5	Sponsors listed in this trial
		Sidney Kimmel Comprehensive Cancer Center